SPP-037 is an orally active selective inhibitor of ST6GAL1, with an IC50 of 3.59 µM. It exhibits anti-migration activity against MDA-MB-231 cells by inhibiting integrin alpha2,6-sialylation and the integrin-FAK-paxillin pathway. In MDA-MB-231 xenograft mouse models, SPP-037 demonstrates antitumor properties. This compound is applicable in breast cancer research.
Formel:
C36H50ClN3O9S
Target-Kategorie:
Endogenous Metabolite|||FAK
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
